Back
Dorman Products Vs. Monopar Therapeutics Industry Stock Comparison
Buy
60
DORM
Dorman Products
Last Price:
$130.20
Seasonality Move:
6.56%
Buy
73
MNPR
Monopar Therapeutics
Last Price:
$36.97
Seasonality Move:
-15.23%
Buy
60
Dorman Products (DORM)
is a Buy
Is Dorman Products a Buy, Sell or Hold?
-
The current Dorman Products [DORM] share price is $130.40. The Score for DORM is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
DORM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $36.90. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DORM Stock Price Chart
What is Dorman Products's stock price today?
-
The Dorman Products share price today is $130.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DORM is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $36.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
DORM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.66 | Buy |
Relative Strength Index (14 RSI): | 65.55 | Buy |
Chaikin Money Flow: | -7873 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.78 - 126.54) | Buy |
Bollinger Bands (100): | (117.87 - 131.57) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 46.85 | Sell |
Chaikin Money Flow: | 2073 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.24 - 43.02) | Sell |
Bollinger Bands (100): | (28.59 - 43.43) | Buy |
DORM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.88 | Buy |
20-day SMA: | 120.53 | Buy |
50-day SMA: | 120.46 | Buy |
200-day SMA: | 122.09 | Buy |
8-day EMA: | 128.26 | Buy |
20-day EMA: | 121.54 | Buy |
50-day EMA: | 98.03 | Buy |
200-day EMA: | 40.99 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.68 | Sell |
20-day SMA: | 40.35 | Sell |
50-day SMA: | 37.36 | Sell |
200-day SMA: | 23.35 | Buy |
8-day EMA: | 37.87 | Sell |
20-day EMA: | 38.71 | Sell |
50-day EMA: | 37.76 | Sell |
200-day EMA: | 26.76 | Buy |
Dorman Products Earnings Growth & DORM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.02 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.
Dorman Products Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |